SUR-1 Antibodies

Santa Cruz Biotechnology offers a broad range of SUR-1 monoclonal antibodies for advanced research in cellular signaling and metabolism. SUR-1 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SUR-1, also known as the sulfonylurea receptor 1, plays a critical role in regulating insulin secretion and glucose homeostasis. It is a key component of the ATP-sensitive potassium channels in pancreatic beta cells, influencing cellular excitability and insulin release in response to glucose levels. Understanding the function of SUR-1 is essential for elucidating mechanisms underlying diabetes and other metabolic disorders. SUR-1 monoclonal antibodies enable researchers to investigate cellular responses to glucose fluctuations and examine the molecular mechanisms of insulin secretion. Studying SUR-1 expression patterns and interactions provides valuable insights into pancreatic beta cell function and dysfunction. Research utilizing SUR-1 monoclonal antibodies contributes to developing targeted treatments for metabolic diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of diabetes and metabolic regulation.